Fen Xu

Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

Jinhua Yan, Bin Yao, Hongyu Kuang et al. · Hepatology · 2018 · 242 citations · Full text

Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+/− Mice: A Role of Lipid Mobilization and Inflammation

Fen Xu, Zhan‐Guo Gao, Jin Zhang et al. · Endocrinology · 2010 · 225 citations · Full text

GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1

Fen Xu, Beisi Lin, Xiaobin Zheng et al. · Diabetologia · 2016 · 140 citations · Full text

Obesity, Metabolic Syndrome, Energy Homeostasis +14

SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis

Fen Xu, Zhuo Li, Xiaobin Zheng et al. · Diabetes · 2014 · 112 citations

Immunology, Pathology, Fatty Liver Disease +19

MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy

Yingxin Xian, Jianping Weng, Fen Xu · Chinese Medical Journal · 2020 · 105 citations · Full text